Imported-post
-
VUMC’s program to repurpose drugs lands international acclaim
Vanderbilt University Medical Center is attracting international attention for its proposal to repurpose existing drugs for new uses in ways that can dramatically improve access to medicines by billions of people throughout the world. Read MoreJuly 23, 2020
-
Cellular antiviral defenses
A cellular RNA quality control mechanism was known to restrict replication of RNA viruses. Vanderbilt researchers have discovered it is also antiviral against DNA viruses. Read MoreJuly 23, 2020
-
Amidon named 2020 Vanderbilt Prize Student Scholar
Katherine Amidon, a PhD student in the Department of Biological Sciences at Vanderbilt University, has been selected as the 2020 Vanderbilt Prize Student Scholar. Read MoreJuly 22, 2020
-
Study points to potential new approach to treating neurodegenerative diseases like glaucoma and Alzheimer’s disease
Researchers at Vanderbilt University Medical Center have shown for the first time that when one optic nerve in the eye is damaged, as in glaucoma, the opposite optic nerve comes to the rescue by sharing its metabolic energy. Read MoreJuly 20, 2020
-
4D printed thermite could make welding in space and combat zones easier, safer
A recent mechanical engineering doctoral graduate has created a material for welding in extreme conditions that could minimize equipment needed and operator hazards. Read MoreJuly 20, 2020
-
BME junior selected for inaugural NIH program to pursue biomedical graduate degree
Lucy Britto is one of six Vanderbilt undergraduates selected as a MARC scholar in the inaugural 2020 cohort of an innovative National Institutes of Health program. Read MoreJuly 15, 2020
-
Antibody research at Vanderbilt University Medical Center shows promise in fight against COVID-19
Based on positive results in preclinical studies reported today, potently neutralizing antibodies identified by researchers at Vanderbilt University Medical Center are showing promise as a potential therapy for preventing and treating COVID-19. Read MoreJuly 15, 2020
-
VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial
An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial. Read MoreJuly 14, 2020
-
Vanderbilt bioengineer’s trailblazing cancer research receives $1M W. M. Keck Foundation grant
A bold engineering approach by a Vanderbilt University researcher to sort breast cancer cells based on their behavior first has produced compelling data that show less migratory cells create more metastases, contradicting the prevailing hypothesis on how cancer spreads. Read MoreJuly 14, 2020
-
New tools to study bioactive lipids
Vanderbilt researchers have identified and characterized inhibitors of an enzyme that synthesizes lipid signaling molecules with roles in energy balance, inflammation and addiction. Read MoreJuly 14, 2020